Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 157,431 |
|
|||||
| News | - | ||||||
| Day High | 4.60 | Low High |
|||||
| Day Low | 4.48 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Zevra Therapeutics Inc | ZVRA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 4.52 | 16:25:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 4.52 | 4.48 | 4.60 | 4.52 | 4.52 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,876 | 157,431 | $ 4.55 | $ 716,023 | - | 3.89 - 7.28 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:20:00 | formt | 280 | $ 4.52 | USD |
Zevra Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 163.71M | 36.22M | - | 27.46M | -46.05M | -1.27 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Zevra Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ZVRA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 4.49 | 4.676 | 4.39 | 4.54 | 178,638 | 0.03 | 0.67% |
| 1 Month | 5.15 | 5.49 | 4.39 | 4.83 | 244,714 | -0.63 | -12.23% |
| 3 Months | 5.90 | 7.28 | 4.39 | 5.79 | 254,616 | -1.38 | -23.39% |
| 6 Months | 4.39 | 7.28 | 3.89 | 5.55 | 247,971 | 0.13 | 2.96% |
| 1 Year | 5.55 | 7.28 | 3.89 | 5.36 | 233,503 | -1.03 | -18.56% |
| 3 Years | 5.65 | 7.28 | 3.89 | 5.33 | 235,692 | -1.13 | -20.00% |
| 5 Years | 5.65 | 7.28 | 3.89 | 5.33 | 235,692 | -1.13 | -20.00% |
Zevra Therapeutics Description
| Zevra Therapeutics, Inc. is a rare disease therapeutics company. The Company is engaged in creating therapies for diseases with limited or no treatment options. The Company has a diverse portfolio of products and product candidates, which includes a combination of both a clinical-stage pipeline and commercial stage assets. It employs its LAT platform technology to create a portfolio of approved products. Its product candidates include Arimoclomol, KP1077IH, KP1077N and AZSTARYS. Arimoclomol is an orally delivered, investigational product candidate being developed for Niemann-Pick disease type C (NPC). KP1077 is the Company's lead clinical development product candidate, which is being developed as a treatment for idiopathic hypersomnia (IH) and narcolepsy. KP1077 is comprised solely of serdexmethylphenidate (SDX), the Company's prodrug of d-methylphenidate (d-MPH). AZSTARYS is a prodrug for the treatment of ADHD in patients aged six years or older. |
